Skip to main content

Option Care Health Value Stock - Dividend - Research Selection

Bioscrip

ISIN: US68404L2016 , WKN: A2PZEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


3 Highly Ranked Medical Stocks Added to the Zacks Strong Buy List

2024-05-28
Considering the stretched premiums many groundbreaking healthcare companies can command, these medical stocks are worthy of investors' interest given their attractive P/E valuations and the positive trend of earnings estimate revisions.

Will Weakness in Option Care Health, Inc.'s (NASDAQ:OPCH) Stock Prove Temporary Given Strong Fundamentals?

2024-05-21
Option Care Health (NASDAQ:OPCH) has had a rough three months with its share price down 13%. But if you pay close...

Option Care Health Shareholders Back Leadership and Plans

2024-05-17
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Option Care Health to Participate in Upcoming Investor Conferences

2024-05-16
BANNOCKBURN, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: The William Blair 44th Annual Growth Stock Conference, being held in Chicago, on Tuesday, June 4, 2024, including a presentation at 12:00pm CT.The Jefferies Global Healthcare Conference, being held in New York, on Wednesday

Buy Rating Justified for Option Care Health Amid Revenue Growth and Strategic Adaptability

2024-05-15
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and The Pennant Group

2024-05-09
DaVita, Encompass Health, Option Care Health and The Pennant Group have been highlighted in this Industry Outlook article.

Zacks.com featured highlights include Option Care Health, Merchants, Teekay Tankers and GigaCloud

2024-05-09
Option Care Health, Merchants, Teekay Tankers and GigaCloud have been highlighted in this Screen of The Week article.

4 Stocks to Buy in a Thriving Outpatient Home Health Industry

2024-05-08
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.

The Zacks Analyst Blog Highlights DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant

2024-05-08
DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant are included in this Analyst Blog.

4 Must-Buy Profitable Stocks Using Net Income Ratio

2024-05-08
Option Care Health (OPCH), Merchants Bancorp (MBIN), Teekay Tankers (TNK), and GigaCloud Technology (GCT) have been selected as the top picks with a high net income ratio.